Cargando…
BI2536 induces mitotic catastrophe and radiosensitization in human oral cancer cells
BI2536 has been developed as a potential therapeutic agent for various cancers but not in oral cancer cells. Since BI2536 exhibits mitosis-regulating activity which are the most radiosensitive, we hypothesized that BI2536 might modulate the radiosensitivity of oral cancer cells. Human normal fibrobl...
Autores principales: | Cheng, Chieh-Yuan, Liu, Chung-Ji, Huang, Yu-Chuen, Wu, Shu-Hua, Fang, Hsu-Wei, Chen, Yu-Jen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5940398/ https://www.ncbi.nlm.nih.gov/pubmed/29765534 http://dx.doi.org/10.18632/oncotarget.25035 |
Ejemplares similares
-
BI-2536 Promotes Neuroblastoma Cell Death via Minichromosome Maintenance Complex Components 2 and 10
por: Hsieh, Chiao-Hui, et al.
Publicado: (2021) -
BI 2536 induces gasdermin E-dependent pyroptosis in ovarian cancer
por: Huo, Jianting, et al.
Publicado: (2022) -
Costunolide causes mitotic arrest and enhances radiosensitivity in human hepatocellular carcinoma cells
por: Liu, Chia-Yuan, et al.
Publicado: (2011) -
BI-2536 and BI-6727, dual Polo-like kinase/bromodomain inhibitors, effectively reactivate latent HIV-1
por: Gohda, Jin, et al.
Publicado: (2018) -
The Plk1 Inhibitor BI 2536 Temporarily Arrests Primary Cardiac Fibroblasts in Mitosis and Generates Aneuploidy In Vitro
por: Lu, Bo, et al.
Publicado: (2010)